Pittenger & Anderson Inc Insulet Corp Transaction History

Pittenger & Anderson Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$272.48 - $330.23 $2,179 - $2,641	8 Added 24.24%	41 $11,000
Q1 2023 May 10, 2023	BUY	$276.36 - $326.03 $829 - $978	3 Added 10.0%	33 $10,000
Q3 2022 Nov 15, 2022	BUY	$224.6 - $281.45 $1,123 - $1,407	5 Added 20.0%	30 $7,000
Q2 2022 Jul 14, 2022	BUY	$186.4 - $279.02 $1,304 - $1,953	7 Added 38.89%	25 $5,000
Q3 2021 Nov 12, 2021	BUY	$260.36 - $307.27 $1,301 - $1,536	5 Added 38.46%	18 $5,000
Q3 2020 Nov 10, 2020	BUY	$192.55 - $236.59 $385 - $473	2 Added 18.18%	13 $3,000
Q1 2020 Apr 30, 2020	BUY	$130.01 - $216.44 $520 - $865	4 Added 57.14%	11 $2,000
Q4 2019 Feb 12, 2020	BUY	$144.81 - $186.0 $1,013 - $1,302	7 New	7 $1,000

687

62.6M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.4B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Pittenger & Anderson Inc, based on Form 13F filings with the SEC.

Stay updated on Pittenger & Anderson Inc with notifications on news.